Work

Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy‐induced immunosuppression

Year: 2012

Type: article

Source: British Journal of Haematology

DOI: 10.1111/bjh.12077

Authors: Sandra Eketorp Sylvan, Eva Rossmann, Fariba Mozaffari, Anna Porwit, Stefan Norin, Claes Karlsson, Lotta Hansson, Jeanette Lundin, Anders Österborg

Institutions: Karolinska University Hospital, Karolinska Institutet

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Celgene, Karolinska Institutet

OpenAlex ID: W2085286133

FWCI: 1.023

Cites: 10

Cited by: 7

Related to: 10